Literature DB >> 31596377

Prevalence of diabetes mellitus as determined by glycated hemoglobin in the Brazilian adult population, National Health Survey.

Deborah Carvalho Malta1, Bruce Bartholow Duncan2, Maria Inês Schmidt2, Ísis Eloah Machado3, Alanna Gomes da Silva3, Regina Tomie Ivata Bernal1, Cimar Azeredo Pereira4, Giseli Nogueira Damacena5, Sheila Rizzato Stopa6, Luiz Gastão Rosenfeld7, Celia Landman Szwarcwald5.   

Abstract

OBJECTIVE: To analyze the prevalence of diabetes mellitus (DM) according to different diagnostic criteria, in the Brazilian adult population, according to laboratory results from the Brazilian National Health Survey.
METHODS: Analysis of laboratory data from the National Health Survey, collected between 2014 and 2015. The prevalence of diabetes was calculated according to different diagnostic criteria. The prevalence of diabetes was calculated according to the criterion of glycosylated hemoglobin ≥ 6.5% or using medication, using Poisson regression and calculating crude and adjusted PR and 95%CI.
RESULTS: The prevalence of diabetes according to different criteria varies from 6.6 to 9.4%. Intermediate or pre-diabetes hyperglycemia ranged from 6.8 to 16.9%. Considering laboratory criteria or medication use, the prevalence of DM was 8.4 (95%CI 7.65-9.11). The adjusted PR for gender, age, educational level and region was lower for males (PR 0.75; 95%CI 0.63 - 0.89), increased with age: 30 to 34 years (PR 2.32; 95% CI 1.33 - 4.07), 40 to 59 years PR 8.1; 95%CI 4.86 - 13.46), 60 years old or older (PR 12.6; 95%CI 7.1 - 21.0), and higher educational levels was protective (PR 0.8; 95%CI 0.6 - 0.9). Therewas a higher PR in the Central West Region (PR 1.3; 95%CI 1.04 - 1.7), in overweight people (PR 1.8; 95%CI 1.4 - 2.1), and in obese people (PR 3.3; 95%CI 2.6 - 4.1).
CONCLUSION: The prevalence of diabetes was higher in females, people over 30 years of age, in populations with low educational levels, and people who were overweight and obese. The study advances in determining the diabetes situation in the country through laboratory criteria.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31596377     DOI: 10.1590/1980-549720190006.supl.2

Source DB:  PubMed          Journal:  Rev Bras Epidemiol        ISSN: 1415-790X


  12 in total

1.  Sexual Violence and Low Rates of HIV Post-exposure Prophylaxis Access Among Female Sex Workers in Brazil.

Authors:  Acácia Mayra Pereira de Lima; Laio Magno; Carla Gianna Luppi; Célia Landmann Szwarcwald; Alexandre Grangeiro; Elis Passos Santana; Inês Dourado
Journal:  AIDS Behav       Date:  2022-06-10

2.  Cardiovascular Statistics - Brazil 2021.

Authors:  Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Deborah Carvalho Malta; Andreia Biolo; Bruno Ramos Nascimento; Maria de Fatima Marinho de Souza; Andrea Rocha De Lorenzo; Antonio Aurélio de Paiva Fagundes Júnior; Beatriz D Schaan; Fábio Morato de Castilho; Fernando Henpin Yue Cesena; Gabriel Porto Soares; Gesner Francisco Xavier Junior; Jose Augusto Soares Barreto Filho; Luiz Guilherme Passaglia; Marcelo Martins Pinto Filho; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Paolo Blanco Villela; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Pablo Perel; Gregory A Roth; Antonio Luiz Pinho Ribeiro
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

3.  Prevalence of Systemic Arterial Hypertension and Diabetes Mellitus in Individuals with COVID-19: A Retrospective Study of Deaths in Pernambuco, Brazil.

Authors:  Lucas Gomes Santos; Jussara Almeida de Oliveira Baggio; Thiago Cavalcanti Leal; Francisco A Costa; Tânia Rita Moreno de Oliveira Fernandes; Regicley Vieira da Silva; Anderson Armstrong; Rodrigo Feliciano Carmo; Carlos Dornels Freire de Souza
Journal:  Arq Bras Cardiol       Date:  2021-08       Impact factor: 2.667

4.  Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil.

Authors:  Cassyano J Correr; Wendel Coura-Vital; Josélia C Q P Frade; Renata C R M Nascimento; Lúbia G Nascimento; Eliete B Pinheiro; Wesley M Ferreira; Janice S Reis; Karla F S Melo; Roberto Pontarolo; Mônica S A Lenzi; José V Almeida; Hermelinda C Pedrosa; Walter S J João
Journal:  Diabetol Metab Syndr       Date:  2020-10-08       Impact factor: 3.320

5.  Primary care coverage and individual health: evidence from a likelihood model using biomarkers in Brazil.

Authors:  Fernando Antonio Slaibe Postali; Maria Dolores Montoya Diaz; Natalia Nunes Ferreira-Batista; Adriano Dutra Teixeira; Rodrigo Moreno-Serra
Journal:  BMC Health Serv Res       Date:  2021-12-04       Impact factor: 2.655

Review 6.  Arteriosclerosis, atherosclerosis, arteriolosclerosis, and Monckeberg medial calcific sclerosis: what is the difference?

Authors:  Vanessa Prado Dos Santos; Geanete Pozzan; Valter Castelli; Roberto Augusto Caffaro
Journal:  J Vasc Bras       Date:  2021-06-25

Review 7.  Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken.

Authors:  Adriano Alberti; Fabiana Schuelter-Trevisol; Betine Pinto Moehlecke Iser; Eliane Traebert; Viviane Freiberger; Leticia Ventura; Gislaine Tezza Rezin; Bruna Becker da Silva; Fabiana Meneghetti Dallacosta; Leoberto Grigollo; Paula Dias; Gracielle Fin; Josiane Aparecida De Jesus; Fabiane Pertille; Carina Rossoni; Ben Hur Soares; Rudy José Nodari Júnior; Clarissa Martinelli Comim
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

8.  [Costs attributable to obesity, hypertension, and diabetes in the Unified Health System, Brazil, 2018Costos atribuibles a la obesidad, la hipertensión y la diabetes en el Sistema Único de Salud de Brasil, 2018].

Authors:  Eduardo Augusto Fernandes Nilson; Rafaella da Costa Santin Andrade; Daniela Aquino de Brito; Michele Lessa de Oliveira
Journal:  Rev Panam Salud Publica       Date:  2020-04-10

9.  Excess Mortality due to natural causes among whites and blacks during the COVID-19 pandemic in Brazil.

Authors:  Renato Azeredo Teixeira; Ana Maria Nogales Vasconcelos; Ana Torens; Elisabeth Barboza França; Lenice Ishitani; Ana Luiza Bierrenbach; Daisy Maria Xavier de Abreu; Fátima Marinho
Journal:  Rev Soc Bras Med Trop       Date:  2022-01-28       Impact factor: 1.581

10.  The impact of COVID-19 on people with diabetes in Brazil.

Authors:  Mark Thomaz Ugliara Barone; Simone Bega Harnik; Patrícia Vieira de Luca; Bruna Letícia de Souza Lima; Ronaldo José Pineda Wieselberg; Belinda Ngongo; Hermelinda Cordeiro Pedrosa; Augusto Pimazoni-Netto; Denise Reis Franco; Maria de Fatima Marinho de Souza; Deborah Carvalho Malta; Viviana Giampaoli
Journal:  Diabetes Res Clin Pract       Date:  2020-07-03       Impact factor: 8.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.